A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added another major [...] …
Blog Posts
A California-based drugmaker this week updated its contract pharmacy restrictions to impose new claims data submissions for hospitals and prevent [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Q: Tell us some interesting details about your company’s history.
Red Chip entered the 340B scene 24 years ago, just as Hemophilia Treatment Centers (HTCs) were looking to increase
…
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. told a U.S. Senate subcommittee Tuesday that the 340B program [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge’s decision to uphold the government’s authority to pre-approve drugmaker 340B rebate models has drawn praise from providers, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal district judge last Friday allowed a key hospital trade group to intervene in Johnson & Johnson’s (J&J) lawsuit [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
Introduction: Navigating Political Headwinds
As the 2025 political season heats up, federally qualified health centers (FQHCs), hospitals, STD clinics, Ryan White grantees, and other covered entities must brace for another round of uncertainty. With renewed debates around entitlement
…
The California Assembly yesterday approved a bill to prohibit manufacturers from placing 340B contract pharmacy restrictions on grantee covered entities, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A pharmaceutical industry-funded HIV/AIDS advocacy group is taking aim at the 340B program—questioning if it’s “too big to fail”—in a [...] …